These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23060014)

  • 1. Cyclin D1 (CCND1) expression is involved in estrogen receptor beta (ERβ) in human prostate cancer.
    Nakamura Y; Felizola SJ; Kurotaki Y; Fujishima F; McNamara KM; Suzuki T; Arai Y; Sasano H
    Prostate; 2013 May; 73(6):590-5. PubMed ID: 23060014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
    Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
    J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells.
    Chen M; Ni J; Chang HC; Lin CY; Muyan M; Yeh S
    Carcinogenesis; 2009 May; 30(5):841-50. PubMed ID: 19126643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-expression of estrogen receptor β inhibits the proliferation and migration of ovarian clear cell adenocarcinoma cells.
    Zhu J; Hua K; Sun H; Yu Y; Jin H; Feng Y
    Oncol Rep; 2011 Dec; 26(6):1497-503. PubMed ID: 21874257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.
    Fixemer T; Remberger K; Bonkhoff H
    Prostate; 2003 Feb; 54(2):79-87. PubMed ID: 12497580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor beta (ERβ) mediates expression of β-catenin and proliferation in prostate cancer cell line PC-3.
    Lombardi AP; Pisolato R; Vicente CM; Lazari MF; Lucas TF; Porto CS
    Mol Cell Endocrinol; 2016 Jul; 430():12-24. PubMed ID: 27107935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetically altered miR-193b targets cyclin D1 in prostate cancer.
    Kaukoniemi KM; Rauhala HE; Scaravilli M; Latonen L; Annala M; Vessella RL; Nykter M; Tammela TL; Visakorpi T
    Cancer Med; 2015 Sep; 4(9):1417-25. PubMed ID: 26129688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M; Kodet R; Strnad P
    Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of ERalpha and ERbeta in prostate cancer.
    Linja MJ; Savinainen KJ; Tammela TL; Isola JJ; Visakorpi T
    Prostate; 2003 May; 55(3):180-6. PubMed ID: 12692783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2.
    Rossi V; Staibano S; Abbondanza C; Pasquali D; De Rosa C; Mascolo M; Bellastella G; Visconti D; De Bellis A; Moncharmont B; De Rosa G; Puca GA; Bellastella A; Sinisi AA
    J Cell Physiol; 2009 Dec; 221(3):771-7. PubMed ID: 19746436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of estrogen receptor beta (ERβ) regulates the expression of N-cadherin, E-cadherin and β-catenin in androgen-independent prostate cancer cells.
    Silva RS; Lombardi APG; de Souza DS; Vicente CM; Porto CS
    Int J Biochem Cell Biol; 2018 Mar; 96():40-50. PubMed ID: 29341930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
    Väisänen MR; Väisänen T; Jukkola-Vuorinen A; Vuopala KS; Desmond R; Selander KS; Vaarala MH
    Prostate; 2010 Jun; 70(8):817-24. PubMed ID: 20054821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent loss of estrogen receptor-beta expression in prostate cancer.
    Horvath LG; Henshall SM; Lee CS; Head DR; Quinn DI; Makela S; Delprado W; Golovsky D; Brenner PC; O'Neill G; Kooner R; Stricker PD; Grygiel JJ; Gustafsson JA; Sutherland RL
    Cancer Res; 2001 Jul; 61(14):5331-5. PubMed ID: 11454669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.
    Casimiro M; Rodriguez O; Pootrakul L; Aventian M; Lushina N; Cromelin C; Ferzli G; Johnson K; Fricke S; Diba F; Kallakury B; Ohanyerenwa C; Chen M; Ostrowski M; Hung MC; Rabbani SA; Datar R; Cote R; Pestell R; Albanese C
    Cancer Res; 2007 May; 67(9):4364-72. PubMed ID: 17483350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of oestrogen receptor-alpha and oestrogen receptor-beta in prostate cancer.
    Yang GS; Wang Y; Wang P; Chen ZD
    Chin Med J (Engl); 2007 Sep; 120(18):1611-5. PubMed ID: 17908481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis.
    Cheng J; Lee EJ; Madison LD; Lazennec G
    FEBS Lett; 2004 May; 566(1-3):169-72. PubMed ID: 15147889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
    Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
    Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
    Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
    Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastases of prostate cancer express estrogen receptor-beta.
    Lai JS; Brown LG; True LD; Hawley SJ; Etzioni RB; Higano CS; Ho SM; Vessella RL; Corey E
    Urology; 2004 Oct; 64(4):814-20. PubMed ID: 15491740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.